NO20002450L - Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for behandling av senil demens av Alzheimer-type - Google Patents

Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for behandling av senil demens av Alzheimer-type

Info

Publication number
NO20002450L
NO20002450L NO20002450A NO20002450A NO20002450L NO 20002450 L NO20002450 L NO 20002450L NO 20002450 A NO20002450 A NO 20002450A NO 20002450 A NO20002450 A NO 20002450A NO 20002450 L NO20002450 L NO 20002450L
Authority
NO
Norway
Prior art keywords
tetrahydropyridines
alzheimer
treatment
composition
type
Prior art date
Application number
NO20002450A
Other languages
English (en)
Other versions
NO20002450D0 (no
Inventor
Jean-Pierre Maffrand
Philippe Soubrie
Jean-Paul Terranova
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20002450D0 publication Critical patent/NO20002450D0/no
Publication of NO20002450L publication Critical patent/NO20002450L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20002450A 1997-11-14 2000-05-11 Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for behandling av senil demens av Alzheimer-type NO20002450L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
PCT/FR1998/002384 WO1999025363A1 (fr) 1997-11-14 1998-11-09 Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer

Publications (2)

Publication Number Publication Date
NO20002450D0 NO20002450D0 (no) 2000-05-11
NO20002450L true NO20002450L (no) 2000-07-14

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002450A NO20002450L (no) 1997-11-14 2000-05-11 Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for behandling av senil demens av Alzheimer-type

Country Status (27)

Country Link
EP (1) EP1030671A1 (no)
JP (1) JP2001523642A (no)
KR (1) KR100599350B1 (no)
CN (1) CN1243540C (no)
AU (1) AU743228B2 (no)
BG (1) BG64819B1 (no)
BR (1) BR9814035A (no)
CA (1) CA2309966A1 (no)
CO (1) CO4980891A1 (no)
DZ (1) DZ2649A1 (no)
EA (1) EA003255B1 (no)
EE (1) EE04235B1 (no)
HU (1) HUP0100098A3 (no)
ID (1) ID24933A (no)
IL (2) IL136122A0 (no)
IS (1) IS5482A (no)
MY (1) MY120461A (no)
NO (1) NO20002450L (no)
NZ (1) NZ504420A (no)
OA (1) OA11464A (no)
PL (1) PL194597B1 (no)
SA (1) SA98190747B1 (no)
SK (1) SK286040B6 (no)
TR (1) TR200001262T2 (no)
TW (1) TW585766B (no)
UY (1) UY25247A1 (no)
WO (1) WO1999025363A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2379948T3 (es) 2002-06-14 2012-05-07 Toyama Chemical Co., Ltd. Composición medicinal que comprende Tacrine o Donepezil para mejorar la función cerebral
EP1529116B1 (en) * 2002-08-07 2009-07-01 Novartis AG Method for predicting the responsiveness to treatment with rivastigmine based on the ApoE genotyp of dementia patients
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
BRPI0518396A2 (pt) 2004-12-27 2008-11-18 Eisai R&D Man Co Ltd mÉtodo para estabilizaÇço de droga anti-demÊncia
RU2692258C2 (ru) 2014-01-31 2019-06-24 Когнишн Терапьютикс, Инк. Композиции изоиндолина и способы лечения нейродегенеративного заболевания
WO2018213281A1 (en) * 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
KR102224917B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
CN1126546C (zh) * 1995-03-06 2003-11-05 英特纽隆制剂药有限公司 使用胞磷胆碱减少梗塞面积
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
HUP0100098A3 (en) 2001-12-28
JP2001523642A (ja) 2001-11-27
EE04235B1 (et) 2004-02-16
SA98190747B1 (ar) 2006-11-04
CO4980891A1 (es) 2000-11-27
EP1030671A1 (fr) 2000-08-30
PL194597B1 (pl) 2007-06-29
IL136122A (en) 2006-07-05
MY120461A (en) 2005-10-31
EA003255B1 (ru) 2003-02-27
CA2309966A1 (en) 1999-05-27
TR200001262T2 (tr) 2001-01-22
PL340500A1 (en) 2001-02-12
BR9814035A (pt) 2000-09-26
EE200000290A (et) 2001-06-15
IL136122A0 (en) 2001-05-20
HUP0100098A2 (hu) 2001-07-30
BG64819B1 (bg) 2006-05-31
DZ2649A1 (fr) 2004-12-28
WO1999025363A1 (fr) 1999-05-27
KR100599350B1 (ko) 2006-07-12
EA200000412A1 (ru) 2000-12-25
OA11464A (en) 2003-11-18
KR20010032099A (ko) 2001-04-16
AU1160999A (en) 1999-06-07
TW585766B (en) 2004-05-01
SK7112000A3 (en) 2000-10-09
BG104428A (en) 2001-08-31
CN1243540C (zh) 2006-03-01
UY25247A1 (es) 2001-05-31
SK286040B6 (sk) 2008-01-07
ID24933A (id) 2000-08-31
CN1285742A (zh) 2001-02-28
NO20002450D0 (no) 2000-05-11
AU743228B2 (en) 2002-01-24
IS5482A (is) 2000-05-09
NZ504420A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
DE69219378T2 (de) Feingiessverfahren und Zusammensetzung des Modells
HUP0103920A3 (en) Methods and compositions for the prevention and treatment of anemia
DE69612185T2 (de) Bleichverfahren und bleichmittelzusammensetzung
DE59306638D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethylpiperidin-N-oxyl und in seiner 4-Stellung substituierten Derivaten
AU2001239052A1 (en) Compositions for prevention and treatment of dementia
DK0734260T3 (da) Paroxetintabletter og fremgangsmåde til fremstilling deraf
DE69413051D1 (de) Waschmittelzusammensetzungen enthaltend mittel zur verhinderung des anlaufens von silber
HK1044944A1 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
AU1509999A (en) Herbal drug composition for the prevention and treatment of dementia
NO20002450L (no) Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for behandling av senil demens av Alzheimer-type
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
DE69300062T2 (de) Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
EP0714890A3 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
HUT74615A (en) 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical compositions containing the same
HUP0000756A3 (en) Use of levobupivacaine or ropivacaine for producing pharmaceutical compositions suitable for treating migraine
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
HUP9800396A3 (en) Pharmaceutical composition for treating dementia
HU9800511D0 (en) Process for producing 4-{4-[4-(hydroxy-diphenyl)-1-piperidinyl]-1-hydroxy-butyl}-alpha-alpha-dimethyl-phenyl-acetic.acid and phosphorylized derivatives thereof
GR3033316T3 (en) Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders
HUP0102995A3 (en) Agents and method for the protective treatment of wood
ZA989955B (en) Combination of active ingredients for the treatment of senile dementia of the alzheimer type
HK1021314A1 (en) Formulation for the treatment and/or prophylaxis of dementia
KR100248098B1 (en) Pharmaceutical composition for the treatment of dementia
ZA974390B (en) Carboxamide derivatives of pyrrolidine piperidine and hexahydroazepine for the treatment of thrombosis disorders.